(2,5-DIMETHOXYPYRIDIN-4-YL)BORONIC ACID, 95.0%, 250mg

6-BROMO-1H-INDAZOLE-3-CARBOXYLIC ACID, 95%, 1g

1,3-dioxa-8-azaspiro[4.5]decan-2-one hydrochloride, 95.0%, 250mg

Sodium iodide, min. 99.5%, pa, ACS, 100 g, plastic packaging.

(1S)-(6-Methoxyquinolin-4-yl)((2R,4S,5R)-5-vinylquinuclidin-2-yl)methanol, tech, 10g

3,4-Dimethoxy-2-methylbenzoic acid, 95.0%, 5g

1-(2-methyl-1H-1,3-benzodiazol-6-yl)methanamine dihydrochloride, 95.0%, 250mg

methyl 2-methyl-3-{[(thiophen-2-yl)methyl]amino}propanoate, 95.0%, 10g

1-Phenyl-3-(2,4,6-trimethylphenyl)-2-pyrazoline>98.0%(GC)5g

1-Methyl-4-(4-nitrophenyl)piperidine-2,6-dione, 97%, 250mg

METHYL 1-(1-BENZYL-1H-PYRAZOL-4-YL)-1H-INDOLE-3-CARBOXYLATE, 90.0%, 250mg

ETHYL 1-(TERT-BUTYL)-1H-1,2,3-TRIAZOLE-4-CARBOXYLATE, 95.0%, 250mg

4-(Pyrrolidine-1-carbonyl)benzaldehyde, 95.0%, 1g